ADAGE CAPITAL PARTNERS GP, L.L.C. – Sarepta Therapeutics, Inc. Transaction History
ADAGE CAPITAL PARTNERS GP, L.L.C. portfolio value:
$97.82M
portfolio value
ADAGE CAPITAL PARTNERS GP, L.L.C. quarter portfolio value change:
+47.47%
quarter
Sarepta Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -30.04% | -380K shares | 3.00M | $110.54 | 885K |
| Q2 2022 | share | Increase | +24.63% | 250K shares | 15.53M | $74.96 | 1.26M |
| Q1 2022 | share | Increase | +56.15% | 365K shares | 20.75M | $78.12 | 1.01M |
| Q4 2021 | share | Increase | +62.50% | 250K shares | 21.54M | $90.59 | 650K |
| Q3 2021 | share | Increase | +11.19% | 40.24K shares | 9.02M | $92.48 | 400K |
| Q2 2021 | share | Increase | 0.00% | 359.75K shares | 27.96M | $77.74 | 359.75K |
| Q1 2021 | share | Decrease | -100.00% | -300K shares | -51.14M | $74.53 | 0 |
| Q4 2020 | share | Decrease | -64.71% | -550K shares | -68.21M | $170.49 | 300K |
| Q3 2020 | share | Decrease | -22.73% | -250K shares | -57.00M | $140.43 | 850K |
| Q2 2020 | share | Decrease | -45.68% | -925K shares | -21.71M | $160.34 | 1.1M |
| Q1 2020 | share | Increase | +86.24% | 937.67K shares | 57.77M | $97.82 | 2.02M |
| Q4 2019 | share | Decrease | -36.96% | -637.62K shares | 10.38M | $129.04 | 1.08M |
| Q3 2019 | share | Increase | +43.75% | 524.95K shares | -52.41M | $75.32 | 1.72M |
| Q2 2019 | share | Decrease | -27.27% | -450K shares | -14.32M | $151.95 | 1.2M |
| Q1 2019 | share | Decrease | -29.79% | -700.14K shares | -59.80M | $119.19 | 1.65M |
| Q4 2018 | share | Increase | +80.78% | 1.05M shares | 46.50M | $109.13 | 2.35M |
| Q3 2018 | share | Increase | +23.03% | 243.38K shares | 70.3M | $161.51 | 1.3M |
| Q2 2018 | share | Increase | +956.61% | 956.61K shares | 132.25M | $132.18 | 1.05M |
| Q1 2018 | share | Increase | 0.00% | 100K shares | 7.40M | $74.09 | 100K |